AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
16min chapter
Serial Success With Triumvira's Rob Williamson
Business Of Biotech
Innovative Therapy Approaches and Evolving Priorities in Cancer Treatment
The chapter explores a novel therapy targeting Glottin 18-2 for gastric and gastroesophageal tumors, highlighting its positive outcomes and focus on safety for redosing and outpatient use. It delves into the challenges of gene editing precision in therapeutic interventions and expresses optimism for progressing companies in this field. Additionally, the chapter discusses the shift in attitudes towards investment risks in biotech partnerships, emphasizing the importance of strategic decisions and creating lasting value in the industry.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode